There may be slightly higher risks associated with pre-market and after-hours trading than during regular market hours. Due to the fact that issuers often announce critical financial information outside of regular trading hours, extended-hours trading may result in wider spreads for particular securities. After-hours trades for Fresenius Medical Care AG & Co. KGaA ADR (FMS) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.06, or -0.35%, to $17.02. The Fresenius Medical Care AG & Co. KGaA ADR has recorded 11,551 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Fresenius Medical Care continues to execute on turnaround plan and raises 2023 earnings outlook due to strong operational performance in first nine months and solid business outlook for the fourth quarter.
As a NYSE listed company, FMS falls under the Healthcare sector while operating within the Medical Care Facilities industry segment. The current market capitalization of Fresenius Medical Care AG & Co. KGaA ADR is $10.02B. A total of 0.52 million shares were traded on the day, compared to an average of 529.44K shares.
Aside from predicting where a stock will go, investors also consider insider trades as an indicator of the stock’s future direction. During the recent three months, FMS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 1 BUYs and 0 SELLs from insiders. Insiders purchased 3,295 shares during that period but sold 0.
Investors prefer companies that pay dividends because dividends generate immediate cash flow and indicate a positive outlook. Fresenius Medical Care AG & Co. KGaA ADR pays an annual dividend of $0.52, resulting in a dividend yield of 3.06%, and it has a price to earnings (P/E) ratio of 16.20. FMS’s most recent ex-dividend date was 5/17/2023 when it declared a $0.7086 quarterly dividend that was paid in cash on 6/1/2023. Previously, the company paid the dividend on 5/27/2022 with an ex-dividend date of 5/13/2022. The FMS stock dividend was $0.7093 per share in cash.
In spite of price targets being rarely accurate, it tends to exert some kind influence from time to time, and was often accepted by the market as having some value. According to analysts who have offered 12-month price targets for FMS in the last 3 months, the mean price target is $21.90 with high estimates of $28.67 and low estimates of $12.74. In terms of 52-week highs and lows, FMS has a high of $27.72 and a low of $13.95.
As of this writing, FMS has an earnings estimate of $0.33 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of $0.33 per share and a lower estimate of $0.33. The company reported an EPS of $0.29 in the last quarter, which was 123.10% higher than expectations of $0.13.
Balance Sheet Annually/Quarterly
The balance sheet of a company shows what assets and liabilities a company has, as well as the amount, equity investors have invested. With the help of this information, a company’s financial ratios can be calculated to give investors an overview of the company’s prospects. FMS’s latest balance sheet shows that the firm has $1.62B in Cash & Short Term Investments as of fiscal 2021. There were $13.32B in debt and $7.26B in liabilities at the time. Its Book Value Per Share was $25.27, while its Total Shareholder’s Equity was $13.98B.
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for FMS is Buy with a score of 3.13.